Company Filing History:
Years Active: 1999-2005
Title: The Innovative Contributions of Magnus Dahlbäck
Introduction
Magnus Dahlbäck is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of aerosol drug formulations, holding a total of 2 patents. His work has had a considerable impact on the development of inhalation therapies.
Latest Patents
Dahlbäck's latest patents include innovative aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides. These aerosol formulations are designed for use in pressurized metered dose inhalers and comprise a hydrofluoroalkane propellant, a medicament for inhalation, and a surfactant, which can be a C–C fatty acid or salt thereof, a bile salt, a phospholipid, or an alkyl saccharide. Another significant patent is a method and system for measuring a dose of drug inhaled, which enhances the accuracy of drug delivery in inhalation therapies.
Career Highlights
Throughout his career, Dahlbäck has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Astra Aktiebolag. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and delivery systems.
Collaborations
Dahlbäck has collaborated with several professionals in his field, including Kjell Bäckström and Ann Charlotte Johansson. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Magnus Dahlbäck's contributions to aerosol drug formulations and inhalation therapies highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to enhancing drug delivery systems, making a lasting impact in the pharmaceutical industry.